Literature DB >> 20696623

Endonuclease V-mediated deoxyinosine excision repair in vitro.

Chia-Chia Lee1, Ya-Chien Yang, Steven D Goodman, Yung-Hsu Yu, Shwu-Bin Lin, Jau-Tsuen Kao, Keh-Sung Tsai, Woei-Horng Fang.   

Abstract

Deoxyinosine (dI) in DNA can arise from hydrolytic or nitrosative deamination of deoxyadenosine. It is excised in a repair pathway that is initiated by endonuclease V, the nfi gene product, in Escherichia coli. Repair was studied in vitro using M13mp18 derived heteroduplexes containing a site-specific deoxyinosine. Unpaired dI/G mismatch resides within the recognition site for XhoI restriction endonucleases, permitting evaluation of repair occurring on deoxyinosine-containing DNA strand. Our results show that dI lesions were efficiently repaired in nfi(+)E. coli extracts but the repair level was much reduced in nfi mutant extracts. We subjected the deoxyinosine-containing heteroduplex to a purified system consisting of soluble endonuclease V fusion protein, DNA polymerase I, and DNA ligase, along with the four deoxynucleoside triphosphates. Interestingly we found these three proteins alone are sufficient to process the dI lesion efficiently. We also found that the 3'-exonuclease activity of DNA polymerase I is sufficient to remove the dI lesion in this minimum reconstituted assay.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20696623     DOI: 10.1016/j.dnarep.2010.07.007

Source DB:  PubMed          Journal:  DNA Repair (Amst)        ISSN: 1568-7856


  12 in total

Review 1.  Endonuclease V: an unusual enzyme for repair of DNA deamination.

Authors:  Weiguo Cao
Journal:  Cell Mol Life Sci       Date:  2012-12-20       Impact factor: 9.261

2.  DNA editing in DNA/RNA hybrids by adenosine deaminases that act on RNA.

Authors:  Yuxuan Zheng; Claire Lorenzo; Peter A Beal
Journal:  Nucleic Acids Res       Date:  2017-04-07       Impact factor: 16.971

3.  Proofreading and DNA Repair Assay Using Single Nucleotide Extension and MALDI-TOF Mass Spectrometry Analysis.

Authors:  Kang-Yi Su; Steven D Goodman; Hung-Ming Lai; Rong-Syuan Yen; Wei-Yao Hu; Wern-Cherng Cheng; Liang-In Lin; Ya-Chien Yang; Woei-Horng Fang
Journal:  J Vis Exp       Date:  2018-06-19       Impact factor: 1.355

Review 4.  Alternative excision repair pathways.

Authors:  Akira Yasui
Journal:  Cold Spring Harb Perspect Biol       Date:  2013-06-01       Impact factor: 10.005

5.  Deoxyinosine repair in nuclear extracts of human cells.

Authors:  Chia-Chia Lee; Ya-Chien Yang; Steven D Goodman; Shi Chen; Teng-Yung Huang; Wern-Cherng Cheng; Liang-In Lin; Woei-Horng Fang
Journal:  Cell Biosci       Date:  2015-09-08       Impact factor: 7.133

6.  Crystal structure and MD simulation of mouse EndoV reveal wedge motif plasticity in this inosine-specific endonuclease.

Authors:  Meh Sameen Nawaz; Erik Sebastian Vik; Mia Elise Ronander; Anne Marthe Solvoll; Pernille Blicher; Magnar Bjørås; Ingrun Alseth; Bjørn Dalhus
Journal:  Sci Rep       Date:  2016-04-25       Impact factor: 4.379

Review 7.  Diversity of Endonuclease V: From DNA Repair to RNA Editing.

Authors:  Isao Kuraoka
Journal:  Biomolecules       Date:  2015-09-24

8.  The human homolog of Escherichia coli endonuclease V is a nucleolar protein with affinity for branched DNA structures.

Authors:  Cathrine Fladeby; Erik Sebastian Vik; Jon K Laerdahl; Christine Gran Neurauter; Julie E Heggelund; Eirik Thorgaard; Pernille Strøm-Andersen; Magnar Bjørås; Bjørn Dalhus; Ingrun Alseth
Journal:  PLoS One       Date:  2012-11-05       Impact factor: 3.240

9.  Human endonuclease V is a ribonuclease specific for inosine-containing RNA.

Authors:  Yoko Morita; Toshihiro Shibutani; Nozomi Nakanishi; Kazuko Nishikura; Shigenori Iwai; Isao Kuraoka
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

10.  Structural insights into DNA repair by RNase T--an exonuclease processing 3' end of structured DNA in repair pathways.

Authors:  Yu-Yuan Hsiao; Woei-Horng Fang; Chia-Chia Lee; Yi-Ping Chen; Hanna S Yuan
Journal:  PLoS Biol       Date:  2014-03-04       Impact factor: 8.029

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.